ENLARGED ADIPOCYTES FROM SUBCUTANEOUS VS. VISCERAL ADIPOSE TISSUE DIFFERENTIALLY CONTRIBUTE TO METABOLIC DYSFUNCTION AND ATHEROGENIC RISK OF PATIENTS WITH OBESITY